Schlosser, Pascal http://orcid.org/0000-0002-8460-0462
Zhang, Jingning
Liu, Hongbo
Surapaneni, Aditya L.
Rhee, Eugene P.
Arking, Dan E.
Yu, Bing
Boerwinkle, Eric
Welling, Paul A.
Chatterjee, Nilanjan
Susztak, Katalin
Coresh, Josef
Grams, Morgan E.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (431984000, 192904750, 466308205, 523737608)
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK124399, R01 DK124399)
National Heart, Lung, and Blood Institute (K24 HL155861, R01DK108803)
National Human Genome Research Institute (R01 546 HG010480-01)
Article History
Received: 4 August 2022
Accepted: 15 June 2023
First Online: 26 June 2023
Declarations
:
: The African American Study of Kidney Disease and Hypertension clinical protocol was approved by the Institutional Review Board (IRB) of each participating institution (IRB00116062), and each patient provided informed consent.
: All authors have approved the manuscript and give their consent for submission and publication.
: The authors declare that they have no competing interests.